and multiple prostaglandins, including prostaglandin A1, prostaglandin E2, prostaglandin G1, prostaglandin G2, and prostaglandin H1
Additionally, the results of clinical studies of Nrf2 activators in neurodegenerative diseases have been inconsistent, most likely because of genetic differences between individuals (e.g., NLRP3 or NFE2L2), the stage of the disease at intervention, and the differences between the complex pathology of human PD and toxin-based animal models
The combination is potent because it addresses psoriasis at both the regulatory level, why the immune system is attacking, and the effector level, the specific inflammatory signals doing the damage
99.058% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 04/12/2026 Key Ingredients Tripeptide-copper complex studied for its ability to modulate over 4,000 human genes
GHK-Cu appears in research contexts involving copper peptide research, extracellular matrix models, topical formulation studies, skin and hair follicle research
10.1002/jnr.22373 J